{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:22:04Z","timestamp":1793355724650,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":116,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vaccine.2023.02.060","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:00:07Z","timestamp":1677632407000},"page":"A25-A34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S1","title":["Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020"],"prefix":"10.1016","volume":"41","author":[{"given":"Roopa","family":"Darwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladayo","family":"Biya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Jorba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al Safadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Franka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Durry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.02.060_b0005","doi-asserted-by":"crossref","unstructured":"Hampton LM, Farrell M, Ramirez-Gonzalez A, Menning L, Shendale S, Lewis I, Rubin J, Garon J, Harris J, Hyde T, Wassilak S, Patel M, Nandy R, Chang-Blanc D, Immunization Systems Management Group of the Global Polio Eradication Initiative. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine \u2014 Worldwide, 2016. Morbidity and Mortality Weekly Report, 2016; 65(35): 934\u2013938. https:\/\/www.jstor.org\/stable\/24858956.","DOI":"10.15585\/mmwr.mm6535a3"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.060_b0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/risa.13555","article-title":"Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart","volume":"41","author":"Kalkowska","year":"2021","journal-title":"Risk Anal"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2023.02.060_b0015","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2023.02.060_b0020","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.15585\/mmwr.mm6845a4","article-title":"Update on vaccine-derived poliovirus outbreaks\u2014worldwide, January 2018\u2013June 2019","volume":"68","author":"Jorba","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.02.060_b0025","unstructured":"World Health Organization. Standard operating procedures: responding to a poliovirus event or outbreak \u2013 version 4; 2020. p. 25. Retrieved from https:\/\/apps.who.int\/iris\/handle\/10665\/363627."},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.060_b0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0950268816002569","article-title":"Wild and vaccine-derived poliovirus circulation, and implications for polio eradication","volume":"145","author":"Lopalco","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"6489","key":"10.1016\/j.vaccine.2023.02.060_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.02.060_b0040","unstructured":"World Health Organization. International Health Regulations (2005), 2nd ed.; 2008. Retrieved from http:\/\/www.who.int\/ihr\/publications\/9789241596664\/en."},{"key":"10.1016\/j.vaccine.2023.02.060_b0045","unstructured":"Global Polio Eradication Initiative Polio Information System. SIA data dictionary; 2020. Retrieved from https:\/\/extranet.who.int\/polis\/DocumentsComponent\/GetDocument?fileId=593."},{"key":"10.1016\/j.vaccine.2023.02.060_b0050","unstructured":"Global Polio Eradication Initiative. nOPV2: clinical development summary; 2020. Retrieved from https:\/\/polioeradication.org\/wp-content\/uploads\/2021\/02\/nOPV2-Clinical-Development-Summary-1.29-EN.pdf."},{"key":"10.1016\/j.vaccine.2023.02.060_b0055","unstructured":"World Health Organization. First ever vaccine listed under WHO emergency use; 2020. Retrieved from https:\/\/www.who.int\/news\/item\/13-11-2020-first-ever-vaccine-listed-under-who-emergency-use."},{"key":"10.1016\/j.vaccine.2023.02.060_b0060","unstructured":"Global Polio Eradication Initiative. Call to action to support COVID-19 response; 2020. Retrieved from https:\/\/polioeradication.org\/wp-content\/uploads\/2020\/04\/POB-COVID-19-Statement-20200402.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.060_b0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/risa.12019","article-title":"Preeradication vaccine policy options for poliovirus infection and disease control","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:24:25Z","timestamp":1759404265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":13,"alternative-id":["S0264410X23002141"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}